# Oral Melatonin as Neuroprotectant in Preterm Infants

> **NCT04235673** · NA · COMPLETED · sponsor: **Francesca Garofoli** · enrollment: 60 (actual)

## Conditions studied

- Malondialdehyde
- Melatonin

## Interventions

- **DIETARY_SUPPLEMENT:** melatonin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04235673
- **Lead sponsor:** Francesca Garofoli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-25
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-10-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-07-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04235673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04235673, "Oral Melatonin as Neuroprotectant in Preterm Infants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04235673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*